Attached files
| file | filename |
|---|---|
| EX-99.9 - PRESS RELEASE - CBA Florida, Inc. | cbai_ex999.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of
1934
Date of Report (Date of earliest event reported): July 11,
2017
CORD BLOOD AMERICA, INC.
(Exact name of registrant as specified in its
charter)
|
Florida
|
|
000-50746
|
|
90-0613888
|
|
(State
or Other Jurisdiction
|
|
(Commission
|
|
(I.R.S.
Employer
|
|
of
Incorporation)
|
|
File
Number)
|
|
Identification
No.)
|
1857 Helm Drive, Las Vegas, NV 89119
(Address of Principal Executive Office) (Zip
Code)
(702) 914-7250
(Registrant’s telephone number, including area
code)
_______________________________
Copies to:
Stephen Morgan
1857 Helm Drive, Las Vegas, NV 89119
Phone: (702) 914-7250
Fax: (702) 914-7251
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02 Departure of Directors of Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers
The Board of Directors (the “Board”) of Cord Blood
America, Inc. (the “Company”) announced
that Stephen Morgan will resign from
his positions as Interim President, General Counsel, and Corporate
Secretary effective July 19, 2017, in order to pursue other career
opportunities in his home state of Minnesota where he can devote
more time to his family. Mr. Morgan will be available to assist
with the transition and consult with the Company on an as needed
basis.
Effective July 19, 2017, the Company’s board of directors has
named Director and Chairman of the Audit Committee Anthony Snow as
Interim President and Corporate Secretary. The Company shall pay
Mr. Snow five thousand dollars ($5,000) per month while he serves
as Interim President. Mr. Snow will not receive any fees for
serving as a Director or as Chairman of the Audit Committee while
he serves as Interim President.
Anthony Snow, age 41, has been a Director of the Company since
April 2015. He
is a Managing Director at Red Oak Partners. Prior to joining Red
Oak, Mr. Snow worked at Soros Fund Management where he was part of
a two person team that managed a global long/short equity
portfolio. Prior to Soros, Mr. Snow focused on investments in
global equities at both Ardea Capital Management, as part of the
founding team, and Wyper Capital Management. Previously, Mr. Snow
was employed at Lindsay Goldberg, a private equity firm, where he
focused on leveraged buyouts. Mr. Snow began his career at Merrill
Lynch & Co. as an Analyst in the Mergers & Acquisitions
group. He received a B.B.A. with high distinction from the
University of Michigan, concentrating in finance and accounting,
and an M.B.A. from Harvard Business School. Mr. Snow is currently a
Director and Chairman of the Finance Committee of StreetWise
Partners, a New York City non-profit, and also serves on the
Executive Committee.
There are no family relationships between Mr. Snow and any director
or executive officer of the Company, or any person nominated or
chosen by the Company to become a director or executive officer.
There are no arrangements or understandings between Mr. Snow
and any other persons pursuant to which he was selected as Interim
President. Mr. Snow has no direct or indirect material
interest in any transaction or currently proposed transaction
required to be disclosed pursuant to Item 404(a) of Regulation
S-K.
Item 7.01
Regulation FD Disclosure.
The Company issued a press release (the “Press
Release”) announcing Mr.
Morgan’s resignation and the appointment of Mr. Snow as
Interim President and Corporate Secretary.
The information furnished under this Item 7.01 on this Form
8-K, including Exhibit 99.1 attached hereto, shall not be deemed
“filed” for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the
“Exchange
Act”), or otherwise
subject to the liabilities of that section, nor shall it be deemed
incorporated by reference into any other filing under the
Securities Act of 1933, as amended, or the Exchange Act, except as
expressly set forth by specific reference in such a
filing.
Item 9.01 Financial Statements and
Exhibits.
(d) Exhibits
The following Exhibits are furnished herewith:
|
Exhibit No.
|
Description
|
|
Press
Release dated July 11, 2017
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly
authorized.
|
|
CORD BLOOD AMERICA, INC.
|
|
|
|
|
|
(Registrant)
|
|
|
|
|
|
|
|
Date:
July 11, 2017
|
By:
|
/s/Stephen
Morgan
|
|
|
|
|
Interim
President, General Counsel and Corporate Secretary
|
|